Pasar al contenido principal

ESPECIFICACION DE CELULA MADRE HEMATOPOYETICA Y LEUCEMICA

SAF2016-75613-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO INSTITUT HOSPITAL DEL MAR D'INVESTIGACIONS MEDIQUES

Resultados relacionados

Resultados totales (Incluyendo duplicados): 21
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia

  • García Hernández, Violeta
  • Arambilet, David
  • Guillén, Yolanda
  • Lobo-Jarne, Teresa
  • Maqueda, Maria
  • Gekas, Christos
  • González, Jessica
  • Iglesias, Arnau
  • Vega García, Nerea
  • Sentís Carreras, Inés 1990-
  • Trincado Alonso, Juan Luis, 1987-
  • Márquez-López, Ian
  • Heyn, Holger
  • Camós, Mireia
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Understanding the molecular mechanisms that contribute to the appearance of chemotherapy resistant cell populations is necessary to improve cancer treatment. We have now investigated the role of β-catenin/CTNNB1 in the evolution of T-cell Acute Lymphoblastic Leukemia (T-ALL) patients and its involvement in therapy resistance. We have identified a specific gene signature that is directly regulated by β-catenin, TCF/LEF factors and ZBTB33/Kaiso in T-ALL cell lines, which is highly and significantly represented in five out of six refractory patients from a cohort of 40 children with T-ALL. By subsequent refinement of this gene signature, we found that a subset of β-catenin target genes involved with RNA-processing function are sufficient to segregate T-ALL refractory patients in three independent cohorts. We demonstrate the implication of β-catenin in RNA and protein synthesis in T-ALL and provide in vitro and in vivo experimental evidence that β-catenin is crucial for the cellular response to chemotherapy, mainly in the cellular recovery phase after treatment. We propose that combination treatments involving chemotherapy plus β-catenin inhibitors will enhance chemotherapy response and prevent disease relapse in T-ALL patients., This work has been funded by Agencia Estatal de Investigación (SAF2016-75613-R and PID2019-104695RB-I00), Fundación AECC (GC16173697BIGA) and WCR (13-0064). VGH, DA and TL are recipients of Sara Borrell fellowship from ISCIII co-funded by the ESF+ (CD21/00145), FPI (BES-2017-080880) and AECC fellowship (POSTD21975LOBO), respectively.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Blood Development: Hematopoietic Stem Cell Dependence and Independence

  • Dzierzak, Elaine
  • Bigas Salvans, Anna
Evidence of the diversity and multi-layered organization of the hematopoietic system is leading to new insights that may inform ex vivo production of blood cells. Interestingly, not all long-lived hematopoietic cells derive from hematopoietic stem cells (HSCs). Here we review the current knowledge on HSC-dependent cell lineages and HSC-independent tissue-resident hematopoietic cells and how they arise during embryonic development. Classical embryological and genetic experiments, cell fate tracing data, single-cell imaging, and transcriptomics studies provide information on the molecular/cell trajectories that form the complete hematopoietic system. We also discuss the current developmentally informed efforts toward generating engraftable and multilineage blood cells., The authors thank Lluis Espinosa for critical reading of the review and lab members for helpful discussions. We acknowledge the support of the ERC Advanced Grant (341096 DENOVOHSC) to E.D. and SAF2016-75613-R from MINECO and PERIS- SLT002/16/00299 and 2017SGR135 from Generalitat de Catalunya to A.B.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma

  • Gallardo Hernández, Fernando
  • Bertran, Joan
  • López Arribillaga, Erika, 1986-
  • González, Jessica
  • Menéndez, Silvia
  • Sánchez Güerri, Ignacio
  • Colomo Saperas, Luis Alberto
  • Iglesias Coma, Mar
  • Garrido, Marta
  • Santamaría-Babí, Luis Francisco
  • Torres, Ferran
  • Pujol Vallverdú, Ramon Maria
  • Bigas Salvans, Anna
  • Espinosa Blay, Lluís
This work was supported by grants from Instituto de Salud Carlos III FEDER (PT13/0002/002, T13/0010/0005, PI13/00448 and PI16/00437), Ministerio de Economía y Competitividad (SAF2016-75613-R), Fundació la Marató de TV3 (20131210); and the “Xarxa de Bancs de tumors sponsored by Pla Director d’Oncologia de Catalunya (XBTC).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate

  • Thambyrajah, Roshana
  • Maqueda, Maria
  • Neo, Wen Hao
  • Imbach, Kathleen
  • Guillén, Yolanda
  • Grases, Daniela
  • Fadlullah, Zaki
  • Gambera, Stefano
  • Matteini, Francesca
  • Wang, Xiaonan
  • Calero-Nieto, Fernando J.
  • Esteller, Manel
  • Florian, Maria Carolina
  • Porta-Pardo, Eduard
  • Benedito, Rui
  • Göttgens, Berthold
  • Lacaud, Georges
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Hematopoietic stem cells (HSCs) develop from the hemogenic endothelium (HE) in the aorta- gonads-and mesonephros (AGM) region and reside within Intra-aortic hematopoietic clusters (IAHC) along with hematopoietic progenitors (HPC). The signalling mechanisms that distinguish HSCs from HPCs are unknown. Notch signaling is essential for arterial specification, IAHC formation and HSC activity, but current studies on how Notch segregates these different fates are inconsistent. We now demonstrate that Notch activity is highest in a subset of, GFI1 + , HSC-primed HE cells, and is gradually lost with HSC maturation. We uncover that the HSC phenotype is maintained due to increasing levels of NOTCH1 and JAG1 interactions on the surface of the same cell (cis) that renders the NOTCH1 receptor from being activated. Forced activation of the NOTCH1 receptor in IAHC activates a hematopoietic differentiation program. Our results indicate that NOTCH1-JAG1 cis-inhibition preserves the HSC phenotype in the hematopoietic clusters of the embryonic aorta., We thank Sarah Bray and David Sprinzak for critical discussions about cis interactions. We thank Genentech for kindly gifting the anti-JAG1 and anti-NOTCH1 antibodies. We thank all members of Espinosa and Bigas laboratories for helpful discussions and technical support. All illustrations in the manuscript were created with BioRender.com. We also thank the animal facility, FACS facility, and genomic facility of the PRBB and CRUK Manchester Institute for their technical support. This work was funded by grants from SAF2016-75613-R and PID2019-104695RB-I00 from Agencia Estatal de Investigación (AEI) and SLT002/16/00299 from Department of Health, Generalitat de Cataluña and 2021 SGR 00039 from AGAUR, Generalitat de Catalunya. The work in the G.L. laboratory is supported by Blood Cancer UK (19014) and Cancer Research UK Manchester Institute Core Grant (C5759/A27412). The work in R.B. laboratory was supported by a grant from the Ministerio de Ciencia e Innovación (MCIN - PID2020-120252RB-I00). RT is a recipient of BP2016 (00021) and BP/MSCA 2018 (00034) fellowship programs from Generalitat de Catalunya/MSCA. E.P. is a recipient of RYC2019-026415-I. M.M. is a recipient of a grant from the Instituto Carlos III, grant number CA22/00011 (cofunded by the European Social Fund Plus, ESF+, and by the European Union).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development

  • Thambyrajah, Roshana
  • Maqueda, Maria
  • Fadlullah, Zaki
  • Proffitt, Martin
  • Neo, Wen Hao
  • Guillén, Yolanda
  • Casado-Peláez, Marta
  • Herrero-Molinero, Patricia
  • Brujas, Carla
  • Castelluccio, Noemi
  • González, Jessica
  • Iglesias, Arnau
  • Marruecos, Laura
  • Ruiz-Herguido, Cristina
  • Esteller, Manel
  • Mereu, Elisabetta
  • Lacaud, Georges
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Recent findings suggest that Hematopoietic Stem Cells (HSC) and progenitors arise simultaneously and independently of each other already in the embryonic aorta-gonad mesonephros region, but it is still unknown how their different features are established. Here, we uncover IκBα (Nfkbia, the inhibitor of NF-κB) as a critical regulator of HSC proliferation throughout development. IκBα balances retinoic acid signaling levels together with the epigenetic silencer, PRC2, specifically in HSCs. Loss of IκBα decreases proliferation of HSC and induces a dormancy related gene expression signature instead. Also, IκBα deficient HSCs respond with superior activation to in vitro culture and in serial transplantation. At the molecular level, chromatin regions harboring binding motifs for retinoic acid signaling are hypo-methylated for the PRC2 dependent H3K27me3 mark in IκBα deficient HSCs. Overall, we show that the proliferation index in the developing HSCs is regulated by a IκBα-PRC2 axis, which controls retinoic acid signaling., This work was funded by grants from SAF2016-75613-R, PID2019-104695RB-I00, and PDC2021-120817-I00 from Agencia Estatal de Investigación (AEI) and SLT002/16/00299 from Department of Health, Generalitat de Catalunya. The work in G.L. laboratory is supported by Blood Cancer UK (19014) and Cancer Research UK Manchester Institute Core Grant (C5759/A27412). R.T. is a recipient of BP2016(00021) and BP/MSCA 2018(00034) fellowship programs from Generalitat de Catalunya/MSCA. M.M. is a recipient of a grant from the Instituto Carlos III, grant number CA22/00011 (co-funded by the European Social Fund Plus, ESF+, and by the European Union).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The multiple usages of Notch signaling in development, cell differentiation and cancer

  • Bigas Salvans, Anna
  • Espinosa Blay, Lluís
Notch is a well-conserved signaling pathway all through evolution that is crucial to specify different cell fates. Although there is a strong context dependent component in each decision, the basic mechanisms that originate from the interplay among ligands and receptors is greatly preserved. In this review we will cover the latest findings on the different mechanisms for Notch activation and signaling. The regulation of this pathway is essential to understand development, cell differentiation and disease., We would like to thank Erika López-Arribillaga for help in the figure design and the members of the Bigas and Espinosa lab for help ful discussions. Our research is funded by Ministerio de Economía y Competitividad (SAF2016-75613-R), Fundació AECC (Grupos consolidados),Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) (2017SGR135) and PERIS- (SLT002/16/00299) to AB and Instituto de Salud Carlos III(PI16/00437)to LE.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The Polycomb-associated factor PHF19 controls hematopoietic stem cell state and differentiation

  • Vizán, Pedro
  • Gutiérrez, Arantxa
  • Espejo, Isabel
  • García Montolío, Marc, 1991-
  • Lange, Martin
  • Carretero, Ana
  • Lafzi, Atefeh
  • Andrés Aguayo, Luisa de
  • Blanco, Enrique
  • Thambyrajah, Roshana
  • Graf, T. (Thomas)
  • Heyn, Holger
  • Bigas Salvans, Anna
  • Di Croce, Luciano
Adult hematopoietic stem cells (HSCs) are rare multipotent cells in bone marrow that are responsible for generating all blood cell types. HSCs are a heterogeneous group of cells with high plasticity, in part, conferred by epigenetic mechanisms. PHF19, a subunit of the Polycomb repressive complex 2 (PRC2), is preferentially expressed in mouse hematopoietic precursors. Here, we now show that, in stark contrast to results published for other PRC2 subunits, genetic depletion of Phf19 increases HSC identity and quiescence. While proliferation of HSCs is normally triggered by forced mobilization, defects in differentiation impede long-term correct blood production, eventually leading to aberrant hematopoiesis. At molecular level, PHF19 deletion triggers a redistribution of the histone repressive mark H3K27me3, which notably accumulates at blood lineage-specific genes. Our results provide novel insights into how epigenetic mechanisms determine HSC identity, control differentiation, and are key for proper hematopoiesis., The work in the Di Croce laboratory is supported by grants from the Spanish of Economy, Industry, and Competitiveness (MEIC) (BFU2016-75008-P), “Fundación Vencer El Cancer” (VEC), the European Regional Development Fund (FEDER), Fundació “La Marató de TV3,” and from AGAUR. The laboratory of A.B. is supported by SAF2016-75613-R from the Ministerio de Ciencia, Innovación y Universidades. H.H. is a Miguel Servet (CP14/00229) researcher funded by the Spanish Institute of Health Carlos III (ISCIII) and received funding from the European Union’s Horizon 2020 research and innovation programme (MSCA-ITN-2015-675752) and the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE). P.V. was supported by “Fundación Científica de la Asociación Española Contra el Cáncer.”
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Notch ligand Dll4 impairs cell recruitment to aortic clusters and limits blood stem cell generation

  • Porcheri, Cristina
  • Golan, Ohad
  • Calero-Nieto, Fernando J.
  • Thambyrajah, Roshana
  • Ruiz-Herguido, Cristina
  • Wang, Xiaonan
  • Catto, Francesca
  • Guillén, Yolanda
  • Sinha, Roshani, 1989-
  • González, Jessica
  • Kinston, Sarah J.
  • Mariani, Samanta A.
  • Maglitto, Antonio
  • Vink, Chris S.
  • Dzierzak, Elaine
  • Charbord, Pierre
  • Göttgens, Bertie
  • Espinosa Blay, Lluís
  • Sprinzak, David
  • Bigas Salvans, Anna
Hematopoietic stem cells (HSCs) develop from the hemogenic endothelium in cluster structures that protrude into the embryonic aortic lumen. Although much is known about the molecular characteristics of the developing hematopoietic cells, we lack a complete understanding of their origin and the three-dimensional organization of the niche. Here, we use advanced live imaging techniques of organotypic slice cultures, clonal analysis, and mathematical modeling to show the two-step process of intra-aortic hematopoietic cluster (IACH) formation. First, a hemogenic progenitor buds up from the endothelium and undergoes division forming the monoclonal core of the IAHC. Next, surrounding hemogenic cells are recruited into the IAHC, increasing their size and heterogeneity. We identified the Notch ligand Dll4 as a negative regulator of the recruitment phase of IAHC. Blocking of Dll4 promotes the entrance of new hemogenic Gfi1+ cells into the IAHC and increases the number of cells that acquire HSC activity. Mathematical modeling based on our data provides estimation of the cluster lifetime and the average recruitment time of hemogenic cells to the cluster under physiologic and Dll4-inhibited conditions., We thank Thomas Graf (CRG), Minhong Yan (Genentech), Georges Lacaud (CRUK Manchester Institut) and Ralf Adams (Max Planck Institute for Molecular Medicine, Münster) for important mice models and reagents. Thanks to Catherine Robin, Timo Zimmermann and, Raul Gómez-Riera for imaging advice. Thanks to the PRBB facilities: animal facility, flow cytometry, CNAGCRG genomics, confocal microscopy for critical technical assistance. Thanks to Marta Garrido and Luis Galán for experimental support and all the members of the lab for helpful critical discussions. This research was funded by the Ministerio de Economía y Competitividad (SAF2016 -75613-R) and Generalitat de Catalunya, Agència de Gestió d’Ajuds Universitaris i de Recerca (AGAUR) (2017 SGR 135) and PERIS-SLT002/16/00299 to AB and ERC AdG 341096 to ED. CP was a recipient of Juan de la Cierva fellowship (FJCI2014-19870), RT is a recipient of Beatriu de Pinos (2016 BP 00021), JG is a recipient of PERIS (SLT002/16/00070).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate

  • Thambyrajah, Roshana
  • Maqueda, Maria
  • Neo, Wen Hao
  • Imbach, Kathleen
  • Guillén, Yolanda
  • Grases, Daniela
  • Fadlullah, Zaki
  • Gambera, Stefano
  • Matteini, Francesca
  • Wang, Xiaonan
  • Calero-Nieto, Fernando J.
  • Esteller, Manel
  • Florian, Maria Carolina
  • Porta-Pardo, Eduard
  • Benedito, Rui
  • Göttgens, Berthold
  • Lacaud, Georges
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Hematopoietic stem cells (HSCs) develop from the hemogenic endothelium (HE) in the aorta- gonads-and mesonephros (AGM) region and reside within Intra-aortic hematopoietic clusters (IAHC) along with hematopoietic progenitors (HPC). The signalling mechanisms that distinguish HSCs from HPCs are unknown. Notch signaling is essential for arterial specification, IAHC formation and HSC activity, but current studies on how Notch segregates these different fates are inconsistent. We now demonstrate that Notch activity is highest in a subset of, GFI1 + , HSC-primed HE cells, and is gradually lost with HSC maturation. We uncover that the HSC phenotype is maintained due to increasing levels of NOTCH1 and JAG1 interactions on the surface of the same cell (cis) that renders the NOTCH1 receptor from being activated. Forced activation of the NOTCH1 receptor in IAHC activates a hematopoietic differentiation program. Our results indicate that NOTCH1-JAG1 cis-inhibition preserves the HSC phenotype in the hematopoietic clusters of the embryonic aorta., We thank Sarah Bray and David Sprinzak for critical discussions about cis interactions. We thank Genentech for kindly gifting the anti-JAG1 and anti-NOTCH1 antibodies. We thank all members of Espinosa and Bigas laboratories for helpful discussions and technical support. All illustrations in the manuscript were created with BioRender.com. We also thank the animal facility, FACS facility, and genomic facility of the PRBB and CRUK Manchester Institute for their technical support. This work was funded by grants from SAF2016-75613-R and PID2019-104695RB-I00 from Agencia Estatal de Investigación (AEI) and SLT002/16/00299 from Department of Health, Generalitat de Cataluña and 2021 SGR 00039 from AGAUR, Generalitat de Catalunya. The work in the G.L. laboratory is supported by Blood Cancer UK (19014) and Cancer Research UK Manchester Institute Core Grant (C5759/A27412). The work in R.B. laboratory was supported by a grant from the Ministerio de Ciencia e Innovación (MCIN - PID2020-120252RB-I00). RT is a recipient of BP2016 (00021) and BP/MSCA 2018 (00034) fellowship programs from Generalitat de Catalunya/MSCA. E.P. is a recipient of RYC2019-026415-I. M.M. is a recipient of a grant from the Instituto Carlos III, grant number CA22/00011 (cofunded by the European Social Fund Plus, ESF+, and by the European Union).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development

  • Thambyrajah, Roshana
  • Maqueda, Maria
  • Fadlullah, Zaki
  • Proffitt, Martin
  • Neo, Wen Hao
  • Guillén, Yolanda
  • Casado-Peláez, Marta
  • Herrero-Molinero, Patricia
  • Brujas, Carla
  • Castelluccio, Noemi
  • González, Jessica
  • Iglesias, Arnau
  • Marruecos, Laura
  • Ruiz-Herguido, Cristina
  • Esteller, Manel
  • Mereu, Elisabetta
  • Lacaud, Georges
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Recent findings suggest that Hematopoietic Stem Cells (HSC) and progenitors arise simultaneously and independently of each other already in the embryonic aorta-gonad mesonephros region, but it is still unknown how their different features are established. Here, we uncover IκBα (Nfkbia, the inhibitor of NF-κB) as a critical regulator of HSC proliferation throughout development. IκBα balances retinoic acid signaling levels together with the epigenetic silencer, PRC2, specifically in HSCs. Loss of IκBα decreases proliferation of HSC and induces a dormancy related gene expression signature instead. Also, IκBα deficient HSCs respond with superior activation to in vitro culture and in serial transplantation. At the molecular level, chromatin regions harboring binding motifs for retinoic acid signaling are hypo-methylated for the PRC2 dependent H3K27me3 mark in IκBα deficient HSCs. Overall, we show that the proliferation index in the developing HSCs is regulated by a IκBα-PRC2 axis, which controls retinoic acid signaling., This work was funded by grants from SAF2016-75613-R, PID2019-104695RB-I00, and PDC2021-120817-I00 from Agencia Estatal de Investigación (AEI) and SLT002/16/00299 from Department of Health, Generalitat de Catalunya. The work in G.L. laboratory is supported by Blood Cancer UK (19014) and Cancer Research UK Manchester Institute Core Grant (C5759/A27412). R.T. is a recipient of BP2016(00021) and BP/MSCA 2018(00034) fellowship programs from Generalitat de Catalunya/MSCA. M.M. is a recipient of a grant from the Instituto Carlos III, grant number CA22/00011 (co-funded by the European Social Fund Plus, ESF+, and by the European Union).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The multiple usages of Notch signaling in development, cell differentiation and cancer

  • Bigas Salvans, Anna
  • Espinosa Blay, Lluís
Notch is a well-conserved signaling pathway all through evolution that is crucial to specify different cell fates. Although there is a strong context dependent component in each decision, the basic mechanisms that originate from the interplay among ligands and receptors is greatly preserved. In this review we will cover the latest findings on the different mechanisms for Notch activation and signaling. The regulation of this pathway is essential to understand development, cell differentiation and disease., We would like to thank Erika López-Arribillaga for help in the figure design and the members of the Bigas and Espinosa lab for help ful discussions. Our research is funded by Ministerio de Economía y Competitividad (SAF2016-75613-R), Fundació AECC (Grupos consolidados),Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) (2017SGR135) and PERIS- (SLT002/16/00299) to AB and Instituto de Salud Carlos III(PI16/00437)to LE.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Notch ligand Dll4 impairs cell recruitment to aortic clusters and limits blood stem cell generation

  • Porcheri, Cristina
  • Golan, Ohad
  • Calero-Nieto, Fernando J.
  • Thambyrajah, Roshana
  • Ruiz-Herguido, Cristina
  • Wang, Xiaonan
  • Catto, Francesca
  • Guillén, Yolanda
  • Sinha, Roshani, 1989-
  • González, Jessica
  • Kinston, Sarah J.
  • Mariani, Samanta A.
  • Maglitto, Antonio
  • Vink, Chris S.
  • Dzierzak, Elaine
  • Charbord, Pierre
  • Göttgens, Bertie
  • Espinosa Blay, Lluís
  • Sprinzak, David
  • Bigas Salvans, Anna
Hematopoietic stem cells (HSCs) develop from the hemogenic endothelium in cluster structures that protrude into the embryonic aortic lumen. Although much is known about the molecular characteristics of the developing hematopoietic cells, we lack a complete understanding of their origin and the three-dimensional organization of the niche. Here, we use advanced live imaging techniques of organotypic slice cultures, clonal analysis, and mathematical modeling to show the two-step process of intra-aortic hematopoietic cluster (IACH) formation. First, a hemogenic progenitor buds up from the endothelium and undergoes division forming the monoclonal core of the IAHC. Next, surrounding hemogenic cells are recruited into the IAHC, increasing their size and heterogeneity. We identified the Notch ligand Dll4 as a negative regulator of the recruitment phase of IAHC. Blocking of Dll4 promotes the entrance of new hemogenic Gfi1+ cells into the IAHC and increases the number of cells that acquire HSC activity. Mathematical modeling based on our data provides estimation of the cluster lifetime and the average recruitment time of hemogenic cells to the cluster under physiologic and Dll4-inhibited conditions., We thank Thomas Graf (CRG), Minhong Yan (Genentech), Georges Lacaud (CRUK Manchester Institut) and Ralf Adams (Max Planck Institute for Molecular Medicine, Münster) for important mice models and reagents. Thanks to Catherine Robin, Timo Zimmermann and, Raul Gómez-Riera for imaging advice. Thanks to the PRBB facilities: animal facility, flow cytometry, CNAGCRG genomics, confocal microscopy for critical technical assistance. Thanks to Marta Garrido and Luis Galán for experimental support and all the members of the lab for helpful critical discussions. This research was funded by the Ministerio de Economía y Competitividad (SAF2016 -75613-R) and Generalitat de Catalunya, Agència de Gestió d’Ajuds Universitaris i de Recerca (AGAUR) (2017 SGR 135) and PERIS-SLT002/16/00299 to AB and ERC AdG 341096 to ED. CP was a recipient of Juan de la Cierva fellowship (FJCI2014-19870), RT is a recipient of Beatriu de Pinos (2016 BP 00021), JG is a recipient of PERIS (SLT002/16/00070).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The Polycomb-associated factor PHF19 controls hematopoietic stem cell state and differentiation

  • Vizán, Pedro
  • Gutiérrez, Arantxa
  • Espejo, Isabel
  • García Montolío, Marc, 1991-
  • Lange, Martin
  • Carretero, Ana
  • Lafzi, Atefeh
  • Andrés Aguayo, Luisa de
  • Blanco, Enrique
  • Thambyrajah, Roshana
  • Graf, T. (Thomas)
  • Heyn, Holger
  • Bigas Salvans, Anna
  • Di Croce, Luciano
Adult hematopoietic stem cells (HSCs) are rare multipotent cells in bone marrow that are responsible for generating all blood cell types. HSCs are a heterogeneous group of cells with high plasticity, in part, conferred by epigenetic mechanisms. PHF19, a subunit of the Polycomb repressive complex 2 (PRC2), is preferentially expressed in mouse hematopoietic precursors. Here, we now show that, in stark contrast to results published for other PRC2 subunits, genetic depletion of Phf19 increases HSC identity and quiescence. While proliferation of HSCs is normally triggered by forced mobilization, defects in differentiation impede long-term correct blood production, eventually leading to aberrant hematopoiesis. At molecular level, PHF19 deletion triggers a redistribution of the histone repressive mark H3K27me3, which notably accumulates at blood lineage-specific genes. Our results provide novel insights into how epigenetic mechanisms determine HSC identity, control differentiation, and are key for proper hematopoiesis., The work in the Di Croce laboratory is supported by grants from the Spanish of Economy, Industry, and Competitiveness (MEIC) (BFU2016-75008-P), “Fundación Vencer El Cancer” (VEC), the European Regional Development Fund (FEDER), Fundació “La Marató de TV3,” and from AGAUR. The laboratory of A.B. is supported by SAF2016-75613-R from the Ministerio de Ciencia, Innovación y Universidades. H.H. is a Miguel Servet (CP14/00229) researcher funded by the Spanish Institute of Health Carlos III (ISCIII) and received funding from the European Union’s Horizon 2020 research and innovation programme (MSCA-ITN-2015-675752) and the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE). P.V. was supported by “Fundación Científica de la Asociación Española Contra el Cáncer.”
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia

  • García Hernández, Violeta
  • Arambilet, David
  • Guillén, Yolanda
  • Lobo-Jarne, Teresa
  • Maqueda, Maria
  • Gekas, Christos
  • González, Jessica
  • Iglesias, Arnau
  • Vega García, Nerea
  • Sentís Carreras, Inés 1990-
  • Trincado Alonso, Juan Luis, 1987-
  • Márquez-López, Ian
  • Heyn, Holger
  • Camós, Mireia
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Understanding the molecular mechanisms that contribute to the appearance of chemotherapy resistant cell populations is necessary to improve cancer treatment. We have now investigated the role of β-catenin/CTNNB1 in the evolution of T-cell Acute Lymphoblastic Leukemia (T-ALL) patients and its involvement in therapy resistance. We have identified a specific gene signature that is directly regulated by β-catenin, TCF/LEF factors and ZBTB33/Kaiso in T-ALL cell lines, which is highly and significantly represented in five out of six refractory patients from a cohort of 40 children with T-ALL. By subsequent refinement of this gene signature, we found that a subset of β-catenin target genes involved with RNA-processing function are sufficient to segregate T-ALL refractory patients in three independent cohorts. We demonstrate the implication of β-catenin in RNA and protein synthesis in T-ALL and provide in vitro and in vivo experimental evidence that β-catenin is crucial for the cellular response to chemotherapy, mainly in the cellular recovery phase after treatment. We propose that combination treatments involving chemotherapy plus β-catenin inhibitors will enhance chemotherapy response and prevent disease relapse in T-ALL patients., This work has been funded by Agencia Estatal de Investigación (SAF2016-75613-R and PID2019-104695RB-I00), Fundación AECC (GC16173697BIGA) and WCR (13-0064). VGH, DA and TL are recipients of Sara Borrell fellowship from ISCIII co-funded by the ESF+ (CD21/00145), FPI (BES-2017-080880) and AECC fellowship (POSTD21975LOBO), respectively.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma

  • Gallardo Hernández, Fernando
  • Bertran, Joan
  • López Arribillaga, Erika, 1986-
  • González, Jessica
  • Menéndez, Silvia
  • Sánchez Güerri, Ignacio
  • Colomo Saperas, Luis Alberto
  • Iglesias Coma, Mar
  • Garrido, Marta
  • Santamaría-Babí, Luis Francisco
  • Torres, Ferran
  • Pujol Vallverdú, Ramon Maria
  • Bigas Salvans, Anna
  • Espinosa Blay, Lluís
This work was supported by grants from Instituto de Salud Carlos III FEDER (PT13/0002/002, T13/0010/0005, PI13/00448 and PI16/00437), Ministerio de Economía y Competitividad (SAF2016-75613-R), Fundació la Marató de TV3 (20131210); and the “Xarxa de Bancs de tumors sponsored by Pla Director d’Oncologia de Catalunya (XBTC).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Blood Development: Hematopoietic Stem Cell Dependence and Independence

  • Dzierzak, Elaine
  • Bigas Salvans, Anna
Evidence of the diversity and multi-layered organization of the hematopoietic system is leading to new insights that may inform ex vivo production of blood cells. Interestingly, not all long-lived hematopoietic cells derive from hematopoietic stem cells (HSCs). Here we review the current knowledge on HSC-dependent cell lineages and HSC-independent tissue-resident hematopoietic cells and how they arise during embryonic development. Classical embryological and genetic experiments, cell fate tracing data, single-cell imaging, and transcriptomics studies provide information on the molecular/cell trajectories that form the complete hematopoietic system. We also discuss the current developmentally informed efforts toward generating engraftable and multilineage blood cells., The authors thank Lluis Espinosa for critical reading of the review and lab members for helpful discussions. We acknowledge the support of the ERC Advanced Grant (341096 DENOVOHSC) to E.D. and SAF2016-75613-R from MINECO and PERIS- SLT002/16/00299 and 2017SGR135 from Generalitat de Catalunya to A.B.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma

  • Gallardo, Fernando|||0000-0002-8996-3828
  • Bertran, Joan
  • López-Arribillaga, Erika|||0000-0002-9451-6635
  • González, Jéssica
  • Menéndez, Silvia
  • Sánchez, Ignacio
  • Colomo, Luis|||0000-0001-5236-5085
  • Iglesias, Mar|||0000-0002-2274-4671
  • Garrido, Marta
  • Santamaría-Babí, Luis Francisco
  • Torres, Ferran|||0000-0002-7355-7913
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Espinosa, Lluis|||0000-0002-2897-4099
Cutaneous T-cell lymphomas (CTCLs) represent different subtypes of lymphoproliferative disorders with no curative therapies for the advanced forms of the disease (namely mycosis fungoides and the leukemic variant, Sézary syndrome). Molecular events leading to CTCL progression are heterogeneous, however recent DNA and RNA sequencing studies highlighted the importance of NF-κB and β-catenin pathways. We here show that the kinase TAK1, known as essential in B-cell lymphoma, is constitutively activated in CTCL cells, but tempered by the MYPT1/PP1 phosphatase complex. Blocking PP1 activity, both pharmacologically and genetically, resulted in TAK1 hyperphosphorylation at residues T344, S389, T444, and T511, which have functional impact on canonical NF-κB signaling. Inhibition of TAK1 precluded NF-κB and β-catenin signaling and induced apoptosis of CTCL cell lines and primary Sézary syndrome cells both in vitro and in vivo. Detection of phosphorylated TAK1 at T444 and T344 is associated with the presence of lymphoma in a set of 60 primary human samples correlating with NF-κB and β-catenin activation. These results identified TAK1 as a potential biomarker and therapeutic target for CTCL therapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Polycomb-associated factor PHF19 controls hematopoietic stem cell state and differentiation

  • Vizán, Pedro|||0000-0002-6787-9940
  • Gutiérrez, Arantxa|||0000-0001-9033-3834
  • Espejo, Isabel
  • García-Montolio, Marc
  • Lange, Martin|||0000-0002-4045-3915
  • Carretero i Romay, Ana|||0000-0001-9377-4926
  • Lafzi, Atefeh|||0000-0003-4237-4847
  • de Andrés-Aguayo, Luisa|||0000-0001-6717-242X
  • Blanco, Enrique|||0000-0001-6261-7370
  • Thambyrajah, Roshana|||0000-0002-3941-760X
  • Graf, Thomas|||0000-0003-2774-4117
  • Heyn, Holger|||0000-0002-3276-1889
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Di Croce, Luciano|||0000-0003-3488-6228
Phf19, a Polycomb subunit, controls hematopoietic stem cells identity and differentiation. Adult hematopoietic stem cells (HSCs) are rare multipotent cells in bone marrow that are responsible for generating all blood cell types. HSCs are a heterogeneous group of cells with high plasticity, in part, conferred by epigenetic mechanisms. PHF19, a subunit of the Polycomb repressive complex 2 (PRC2), is preferentially expressed in mouse hematopoietic precursors. Here, we now show that, in stark contrast to results published for other PRC2 subunits, genetic depletion of Phf19 increases HSC identity and quiescence. While proliferation of HSCs is normally triggered by forced mobilization, defects in differentiation impede long-term correct blood production, eventually leading to aberrant hematopoiesis. At molecular level, PHF19 deletion triggers a redistribution of the histone repressive mark H3K27me3, which notably accumulates at blood lineage-specific genes. Our results provide novel insights into how epigenetic mechanisms determine HSC identity, control differentiation, and are key for proper hematopoiesis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia

  • García-Hernández, Violeta|||0000-0003-2328-4360
  • Arambilet Mobilla, David|||0000-0001-7372-0082
  • Guillén, Yolanda|||0000-0001-8673-6470
  • Lobo-Jarne, Teresa|||0000-0002-1632-438X
  • Maqueda, Maria|||0000-0001-9304-1714
  • Gekas, Christos|||0000-0002-3429-4145
  • González Miranda, Jessica|||0000-0001-7732-1564
  • Iglesias, Arnau|||0000-0002-7195-7868
  • Vega-García, Nerea
  • Sentís, Inés|||0000-0001-8320-9579
  • Trincado Alonso, Juan Luis, 1987-|||0000-0001-5363-3774
  • Márquez-López, Ian
  • Heyn, Holger|||0000-0002-3276-1889
  • Camós, Mireia|||0000-0003-3658-7942
  • Espinosa, Lluis|||0000-0002-2897-4099
  • Bigas Salvans, Anna|||0000-0003-4801-6899
Understanding the molecular mechanisms that contribute to the appearance of chemotherapy resistant cell populations is necessary to improve cancer treatment. We have now investigated the role of β-catenin/CTNNB1 in the evolution of T-cell Acute Lymphoblastic Leukemia (T-ALL) patients and its involvement in therapy resistance. We have identified a specific gene signature that is directly regulated by β-catenin, TCF/LEF factors and ZBTB33/Kaiso in T-ALL cell lines, which is highly and significantly represented in five out of six refractory patients from a cohort of 40 children with T-ALL. By subsequent refinement of this gene signature, we found that a subset of β-catenin target genes involved with RNA-processing function are sufficient to segregate T-ALL refractory patients in three independent cohorts. We demonstrate the implication of β-catenin in RNA and protein synthesis in T-ALL and provide in vitro and in vivo experimental evidence that β-catenin is crucial for the cellular response to chemotherapy, mainly in the cellular recovery phase after treatment. We propose that combination treatments involving chemotherapy plus β-catenin inhibitors will enhance chemotherapy response and prevent disease relapse in T-ALL patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development

  • Thambyrajah, Roshana|||0000-0002-3941-760X
  • Maqueda, Maria|||0000-0001-9304-1714
  • Fadlullah, Muhammad Zaki|||0000-0002-3111-8090
  • Proffitt, Martin
  • Neo, Wen Hao|||0000-0002-6827-3027
  • Guillén, Yolanda|||0000-0001-8673-6470
  • Casado Pelaez, Marta|||0000-0002-8428-8384
  • Herrero-Molinero, Patricia
  • Brujas, Carla
  • Castelluccio, Noemi|||0000-0003-2635-4889
  • González Miranda, Jessica|||0000-0001-7732-1564
  • Iglesias, Arnau|||0000-0002-7195-7868
  • Marruecos, Laura|||0000-0002-4206-709X
  • Ruiz-Herguido, Cristina
  • Esteller, M|||0000-0003-4490-6093
  • Mereu, Elisabetta|||0000-0001-6101-8472
  • Lacaud, Georges|||0000-0002-5630-2417
  • Espinosa, Lluis|||0000-0002-2897-4099
  • Bigas Salvans, Anna|||0000-0003-4801-6899
Recent findings suggest that Hematopoietic Stem Cells (HSC) and progenitors arise simultaneously and independently of each other already in the embryonic aorta-gonad mesonephros region, but it is still unknown how their different features are established. Here, we uncover IκBα (Nfkbia, the inhibitor of NF-κB) as a critical regulator of HSC proliferation throughout development. IκBα balances retinoic acid signaling levels together with the epigenetic silencer, PRC2, specifically in HSCs. Loss of IκBα decreases proliferation of HSC and induces a dormancy related gene expression signature instead. Also, IκBα deficient HSCs respond with superior activation to in vitro culture and in serial transplantation. At the molecular level, chromatin regions harboring binding motifs for retinoic acid signaling are hypo-methylated for the PRC2 dependent H3K27me3 mark in IκBα deficient HSCs. Overall, we show that the proliferation index in the developing HSCs is regulated by a IκBα-PRC2 axis, which controls retinoic acid signaling.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate

  • Thambyrajah, Roshana|||0000-0002-3941-760X
  • Maqueda, Maria|||0000-0001-9304-1714
  • Neo, Wen Hao|||0000-0002-6827-3027
  • Imbach, Kathleen|||0000-0002-3861-7845
  • Guillén, Yolanda|||0000-0001-8673-6470
  • Grases Mendoza, Daniela|||0000-0002-5981-7248
  • Fadlullah, Zaki
  • Gambera, Stefano|||0000-0003-2998-8502
  • Matteini, Fernando
  • Wang, Xiaonan|||0000-0003-3759-778X
  • Calero-Nieto, Fernando|||0000-0003-3358-8253
  • Esteller, M.|||0000-0003-4490-6093
  • Florian, María Carolina
  • Porta-Pardo, Eduard|||0000-0001-7900-4239
  • Benedito, Rui|||0000-0003-2458-3055
  • Göttgens, Berthold|||0000-0001-6302-5705
  • Lacaud, Georges|||0000-0002-5630-2417
  • Espinosa, Lluis|||0000-0002-2897-4099
  • Bigas Salvans, Anna|||0000-0003-4801-6899
Hematopoietic stem cells (HSCs) develop from the hemogenic endothelium (HE) in the aorta- gonads-and mesonephros (AGM) region and reside within Intra-aortic hematopoietic clusters (IAHC) along with hematopoietic progenitors (HPC). The signalling mechanisms that distinguish HSCs from HPCs are unknown. Notch signaling is essential for arterial specification, IAHC formation and HSC activity, but current studies on how Notch segregates these different fates are inconsistent. We now demonstrate that Notch activity is highest in a subset of, GFI1 +, HSC-primed HE cells, and is gradually lost with HSC maturation. We uncover that the HSC phenotype is maintained due to increasing levels of NOTCH1 and JAG1 interactions on the surface of the same cell (cis) that renders the NOTCH1 receptor from being activated. Forced activation of the NOTCH1 receptor in IAHC activates a hematopoietic differentiation program. Our results indicate that NOTCH1-JAG1 cis-inhibition preserves the HSC phenotype in the hematopoietic clusters of the embryonic aorta.